ArticleWorld journal of urology2026
Association between thrombomodulin and the prevalence of renal calculus: a cross-sectional study from Wuhan central hospital.
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundRenal calculus is a common urological disease with increasing prevalence worldwide. Thrombomodulin (TM) is a marker of endothelial injury and has been associated with various inflammatory conditions. This study aimed to investigate the correlation between plasma thrombomodulin levels and renal calculus.
methodsA total of 805 participants were enrolled in this cross-sectional study, including 577 healthy controls and 228 renal calculus patients. General demographic data and laboratory indicators were collected from the participants. TM levels were measured by chemiluminescence immunoassay. Univariate and multivariate logistic regression models were used to analyze the correlation between TM and renal calculus, and subgroup analyses were performed.
resultsRenal calculus patients showed significantly higher TM levels compared to healthy controls (8.12 vs. 7.6 ng/mL, P = 0.0001). Multivariate analysis revealed TM remained independently associated with renal calculus after adjusting for non-inflammatory covariates (OR = 1.121, P = 0.0031), with the association persisting after additional adjustment for inflammatory markers (OR = 1.176, P = 0.0015). A dose-response trend across TM quartiles was observed, which was partially mediated by inflammatory markers.Patients with UTI and renal calculus complicated by infection showed significantly higher levels of TM, CRP, WBC, and NEU compared to those with simple renal calculus and healthy controls (P < 0.0001).
conclusionsElevated plasma TM levels are significantly associated with increased prevalence of renal calculus.This association may be mediated by endothelial dysfunction and inflammatory responses, suggesting that vascular endothelial dysfunction plays a crucial role in the pathogenesis of renal calculus.
Indexed as
Identifiers
42690461What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.